Physician profile
Robert P Carrillo
NPI 1831149749
$1,527.52
in general payments reported to CMS, 2019-2025
26 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $122 · 2021: $162 · 2022: $617 · 2023: $262 · 2024: $64.02 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $306.61 | 2019-2023 | Collagenase Santyl |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.48 | 2022-2024 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $134.99 | 2025 | Lokelma |
| Portola Pharmaceuticals, LLC | $121.76 | 2020 | |
| Kci USA, INC. | $92.93 | 2019-2022 | |
| Cvrx, INC. | $71.83 | 2022 | |
| Novo Nordisk INC | $62.69 | 2022-2024 | Wegovy |
| Merck Sharp & Dohme LLC | $60.68 | 2022-2023 | Verquvo |
| Abbvie INC. | $56.76 | 2021-2022 | |
| Tactile Systems Technology INC | $43.99 | 2021-2022 | |
| Organogenesis INC. | $35.19 | 2022 | |
| Convatec INC. | $33.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.38 | 2023-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $30.02 | 2021-2023 | |
| Integra Lifesciences Corporation | $22.71 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $22.29 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals, Ltd. | $21.60 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.93 | 2023 | Jardiance |
| Scpharmaceuticals INC. | $20.91 | 2023 | |
| Boston Scientific Corporation | $20.62 | 2022 | |
| Ovik Health, LLC | $17.49 | 2023 | |
| Lilly USA, LLC | $16.12 | 2022 | |
| Abiomed | $15.98 | 2023 | Impella |
| Allergan, INC. | $14.05 | 2019 | |
| Irhythm Technologies, INC. | $13.70 | 2022 | |
| Medela LLC | $9.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carrillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.